Aruba Health Monitor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Health Monitor.

Press releases published on November 12, 2026

10 hours ago

LiveWorld Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

10 hours ago

Olympia Pharmaceuticals to Compound Select Peptides Under HHS Interim Enforcement Policy

Indeterminate GlobeNewswire

10 hours ago

Medicana Expert Highlights: New Study Finds Better One-Year Outcomes After Robot-Assisted Knee Replacement

Indeterminate GlobeNewswire

10 hours ago

Alps Group Inc Launches Pharmaco-Interaction (PCI) Unit via MyGenome, Debuting with CYP450 Drug Interaction Testing

Indeterminate GlobeNewswire

10 hours ago

HOLLYWOOD HAS THE FANS. WHO BUILDS THE BUSINESS?

Indeterminate GlobeNewswire

10 hours ago

Moleculin Secures Australian Patent for Annamycin Formulation Technology

Indeterminate GlobeNewswire

10 hours ago

PRM Establishes West Palm Beach as National Epicenter for Pelvic Health Innovation and Physician Training

Indeterminate GlobeNewswire

10 hours ago

Autonomix Highlights Renal Denervation Strategy and Vision for Illuminating the Nervous System at TCT 2026

Indeterminate GlobeNewswire

10 hours ago

CytoDyn Announces $5 Million Private Investment to Advance Leronlimab in Colorectal Cancer and Other Solid Tumors

Indeterminate GlobeNewswire

10 hours ago

Sol-Gel Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

10 hours ago

Alpha Tau to Host Investor Call to Review New Data from the Alpha DaRT® Recurrent Glioblastoma REGAIN Trial

Indeterminate GlobeNewswire

11 hours ago

Axiom Biosciences Announces Regulation Crowdfunding Offering With Wefunder Community Round

Indeterminate GlobeNewswire

11 hours ago

CollPlant to Begin Trading on Nasdaq Under New Ticker Symbol “OPHI”

Indeterminate GlobeNewswire

11 hours ago

Evaxion announce 2027 financial calendar

Indeterminate GlobeNewswire

11 hours ago

Artelo Biosciences Provides Business Update and Reports 2026 Third Quarter Financial Results

Indeterminate GlobeNewswire

11 hours ago

Hyro Achieves Oracle Validated: Oracle Health Endpoint Validation Expertise for Delivering Proven Agentic AI EHR Integration

Indeterminate GlobeNewswire

11 hours ago

Avalyn Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

11 hours ago

Annovis Bio Granted U.S. Patent Covering New Crystalline Form of Buntanetap

Indeterminate GlobeNewswire

11 hours ago

Grace Therapeutics Announces Second Quarter 2027 Financial Results, Provides Business Update

Indeterminate GlobeNewswire

11 hours ago

Kamau Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Nula-cel, a Gene-Corrected Stem Cell Therapy for Sickle Cell Disease

Indeterminate GlobeNewswire